← Leaderboards
John Peter Campbell
Oregon Health & Science University
$5,273,396
Attributed
$7,960,581
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,960,581 · 6
By mechanism
R01$6,000,581 · 5
R44$1,960,000 · 1
Top collaborators
- Yifan Jian5 shared
- Yali Jia2 shared
- Karyn Jonas2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Yali Jia$6,803,157
- Thomas Hwang$1,507,875
- Yifan Jian$1,842,606
- Steven T Bailey$2,773,465
- Gangjun Liu$589,710
Others in their field
Other Emerging Leaders on “Blindness”
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Susan Abushakra · Alzheon, Inc.$51,190,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Yunda Huang · Fred Hutchinson Cancer Center$18,031,840
- Andrew S Huhn · Johns Hopkins University$17,756,243
Research focus
BlindnessChildhoodRetinopathy Of PrematurityImagePerformanceDiagnosisEvaluationAlgorithmsTechnologyMeasurementSeveritiesClinical DiagnosisDeep LearningAreaInternationalRetinaFundingArtificial IntelligenceLongitudinal StudiesBlood VesselsDesignClinically SignificantDevicesPrototype
Grant awards (13)
Advancing visible-light OCT in oxygen-induced retinopathy$691,728
R01 · FY2025 · EY
Artificial Intelligence Assisted Panoramic Optical Coherence Tomography Angiography for Retinopathy of Prematurity$625,853
R01 · FY2025 · HD
Advancing visible-light OCT in oxygen-induced retinopathy$623,090
R01 · FY2024 · EY
Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)$52,865
R44 · FY2024 · EY
Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)$1,907,135
R44 · FY2023 · EY
Clinical and genetic analysis of retinopathy of prematurity$598,209
R01 · FY2023 · HD · contact PI
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of Prematurity$377,300
R01 · FY2023 · HD
Clinical and genetic analysis of retinopathy of prematurity$582,821
R01 · FY2022 · HD · contact PI
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of Prematurity$377,300
R01 · FY2022 · HD
Clinical and genetic analysis of retinopathy of prematurity$640,901
R01 · FY2021 · HD · contact PI
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of Prematurity$377,300
R01 · FY2021 · HD
Clinical and genetic analysis of retinopathy of prematurity$764,279
R01 · FY2020 · EY · contact PI
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of Prematurity$341,800
R01 · FY2020 · EY